Clonal population of flucytosine-resistant Candida tropicalis from blood cultures, Paris, France

Emerging Infectious Diseases

Volumn 14, Issue 4, 2008, Pages 557-565

  Desnos Ollivier, Marie ^a   Bretagne, Stéphane ^a,b   Bernède, Claire ^a   Robert, Vincent ^c   Raoux, Dorothée ^a   Chachaty, Elisabeth ^d   Forget, Elisabeth ^e   Lacroix, Claire ^f   Dromer, Françoise ^a   Bouges Michel, Claire ^g   Poilane, Isabelle ^h   Bougnoux, Marie Elisabeth ^i,t   Dunand, Jean ⁱ   Galeazzi, Guy ^j   Botterel, Françoise ^b,l   Fauchet, Nathalie ^k   Bonnal, Christine ^l   Eloy, Odile ^m   Lawrence, Christine ⁿ   David, Marie Françoise ^o   Mihaila, Liliana ^o   Adam, Olivier ^d   Chochillon, Christian ^p   Paugam, André ^q   Baixench, Marie Thérèse ^q   Cornet, Muriel ^r   Escande, Marie Christine ^s   Challier, Svetlana ^t   Dannaoui, Eric ^u   Datry, Annick ^v   Laklache, Houria ^v   Lmimouni, Bader ^v   Brun, Sophie ^v   Poirot, Jean Louis ^w   Moissenet, Didier ^x   Develoux, Michel ^y   Bonacorsi, Stéphane ^z   more..

^a INSTITUT PASTEUR   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e BEAUJON HOSPITAL   (France)

^f SAINT LOUIS HOSPITAL   (France)

^g AVICENNE HOSPITAL   (France)

^h HÔPITAL JEAN VERDIER   (France)

ⁱ HÔPITAL AMBROISE PARÉ   (France)

^j HÔPITAL LOUIS MOURIER   (France)

^k CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^l BICÊTRE HOSPITAL   (France)

^m CENTRE HOSPITALIER DE VERSAILLES   (France)

ⁿ RAYMOND POINCARÉ HOSPITAL   (France)

^o HÔPITAL PAUL BROUSSE   (France)

^p BICHAT HOSPITAL   (France)

^q Hôpital Paul Brousse ^*  (France)

^r HÔTEL DIEU   (France)

^s INSTITUT CURIE   (France)

^t HÔPITAL NECKER ENFANTS MALADES   (France)

^u HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^v PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^w HÔPITAL SAINT ANTOINE   (France)

^x ARMAND TROUSSEAU HOSPITAL   (France)

^y HÔPITAL TENON   (France)

^z HÔPITAL ROBERT DEBRÉ   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUCYTOSINE;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BLOOD CULTURE; CANDIDA TROPICALIS; CANDIDEMIA; FRANCE; FUNGAL GENE; GENE SEQUENCE; GENETIC ANALYSIS; MICROSATELLITE MARKER; MOLECULAR CLONING; MOLECULAR TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; URA3 GENE;

EID: 42049093803     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1404.071083     Document Type: Article

References (27)

1. Odds FC. Ecology of Candida and epidemiology of candidosis. Candida and candidosis: a review and bibliography. 2nd ed. London: Bailliere Tindall; 1988. pp. 68-82.
2. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20:133-63.
3. Pfaller MA, Messer SA, Boyken L, Huynh H, Hollis RJ, Diekema DJ. In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods. Antimicrob Agents Chemother. 2002;46:3518-21.
4. Cuenca-Estrella M, Moore CB, Barchiesi F, Bille J, Chryssanthou E, Denning DW, et al. Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin Microbiol Infect. 2003;9:467-74.
5. de Hoog GS, van den Ende GAH. Molecular diagnostics of clinical strains of filamentous Basidiomycetes. Mycoses. 1998;41:183-9.
6. Masclaux F, Gueho E, de Hoog GS, Christen R. Phylogenetic relationships of human-pathogenic Cladosporium (Xylohypha) species inferred from partial LS rRNA sequences. J Med Vet Mycol. 1995;33:327-38.
7. O'Donnell K. Fusarium and its near relatives. Wallingford (UK): CAB International; 1993.
8. Foulet F, Nicolas N, Eloy O, Botterel F, Gantier JC, Costa JM, et al. Microsatellite marker analysis as a typing system for Candida glabrata. J Clin Microbiol. 2005;43:4574-9.
9. Tavanti A, Davidson AD, Johnson EM, Maiden MC, Shaw DJ, Gow NA, et al. Multilocus sequence typing for differentiation of strains of Candida tropicalis. J Clin Microbiol. 2005;43:5593-600.
10. Armitage P, Berry G. Statistical methods in medical research. 3rd ed. Oxford (UK): Blackwell Publishing; 1994.
11. Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. Toronto; John Wiley & Sons Ltd.; 2000.
12. Cuenca-Estrella M, Diaz-Guerra TM, Mellado E, Rodriguez-Tudela JL. Flucytosine primary resistance in Candida species and Cryptococcus neoformans. Eur J Clin Microbiol Infect Dis. 2001;20:276-9.
13. Moore CB, Walls CM, Denning DW. Comparison of three methods for in vitro susceptibility testing of Candida species with flucytosine. J Antimicrob Chemother. 2003;51:297-304.
14. Alexander BD, Byrne TC, Smith KL, Hanson KE, Anstrom KJ, Perfect JR, et al. Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents. J Clin Microbiol. 2007;45:698-706.
15. Quindos G, Ruesga MT, Martin-Mazuelos E, Salesa R, Alonso-Vargas R, Carrillo-Munoz AJ, et al. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts. Rev Iberoam Micol. 2004;21:63-9.
16. Takakura S, Fujihara N, Saito T, Kudo T, Iinuma Y, Ichiyama S. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. J Antimicrob Chemother. 2004;53:283-9.
17. Nerson D, De Closets F, Dupouy-Camet J, Kures L, Marjollet M, Poirot JL, et al. Antifungal susceptibility of yeasts (and a few filamentous fungi) by a standardized micromethod [in French]. Bulletin de la Société Francaise de Mycologie Médicale. 1987;16:395-8.
18. Fleck R, Dietz A, Hof H. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest. J Antimicrob Chemother. 2007;59:767-71.
19. Almirante B, Rodriguez D, Park BJ, Cuenca-Estrella M, Planes AM, Almela M, et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2005;43:1829-35.
20. Tortorano AM, Peman J, Bernhardt H, Klingspor L, Kibbler CC, Faure O, et al. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis. 2004;23:317-22.
21. Fasoli MO, Kerridge D, Ryley JF. Pathogenicity of 5-fluorocytosine resistant strains of Candida albicans. J Med Vet Mycol. 1990;28:27-34.
22. Waldorf AR, Polak A. Mechanisms of action of 5-fluorocytosine. Antimicrob Agents Chemother. 1983;23:79-85.
23. Hope WW, Tabernero L, Denning DW, Anderson MJ. Molecular mechanisms of primary resistance to flucytosine in Candida albicans. Antimicrob Agents Chemother. 2004;48:4377-86.
24. Coste A, Turner V, Ischer F, Morschhauser J, Forche A, Selmecki A, et al. A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics. 2006;172:2139-56.
25. Baixench MT, Aoun N, Desnos-Ollivier M, Garcia-Hermoso D, Bretagne S, Ramires S, et al. Acquired resistance to echinocandins in Candida albicans: case report and review. J Antimicrob Chemother. 2007;59:1076-83.
26. Vermes A, Guchelaar HJ, Dankert J. Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother. 2000;46:171-9.
27. Papon N, Noël T, Florent M, Gibot-Leclerc S, Jean D, Chastin C, et al. Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance. Antimicrob Agents Chemother. 2007;51:369-71.